About the Authors
- William S. Pomat
-
Contributed equally to this work with: William S. Pomat, Anita H. J. van den Biggelaar
Affiliations Papua New Guinean Institute of Medical Research, Goroka, Papua New Guinea, Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia
- Anita H. J. van den Biggelaar
-
Contributed equally to this work with: William S. Pomat, Anita H. J. van den Biggelaar
Current address: Crucell, Leiden, The Netherlands
Affiliation Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia
- Suparat Phuanukoonnon
-
Affiliation Papua New Guinean Institute of Medical Research, Goroka, Papua New Guinea
- Jacinta Francis
-
Affiliation Papua New Guinean Institute of Medical Research, Goroka, Papua New Guinea
- Peter Jacoby
-
Affiliation Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia
- Peter M. Siba
-
Affiliation Papua New Guinean Institute of Medical Research, Goroka, Papua New Guinea
- Michael P. Alpers
-
Affiliation Centre for International Health, Curtin University, Perth, Western Australia, Australia
- John C. Reeder
-
Affiliations Papua New Guinean Institute of Medical Research, Goroka, Papua New Guinea, Burnet Institute, Melbourne, Victoria, Australia
- Patrick G. Holt
-
Affiliation Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia
- Peter C. Richmond
-
Affiliation School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia
- Deborah Lehmann
-
* E-mail: deborahl@ichr.uwa.edu.au
Affiliation Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia
- for the Neonatal Pneumococcal Conjugate Vaccine Trial Study Team
-
¶Membership of the Neonatal Pneumococcal Conjugate Vaccine Trial Study Team is provided in Acknowledgments
Competing Interests
The authors have read the journal’s policy and have the following conflicts: P Richmond has been a member of vaccine advisory boards for Wyeth and CSL Ltd and has received institutional funding for investigator-initiated research from GlaxoSmithKline Biologicals and Merck and received travel support from Pfizer and Baxter to present study data at international meetings. D Lehmann has been a member of the GSK Australia Pneumococcal-Haemophilus influenzae-Protein D conjugate vaccine (“Phid-CV”) Advisory Panel, has received support from Pfizer Australia and GSK Australia to attend conferences, has received an honorarium from Merck Vaccines to give a seminar at their offices in Pennsylvania and to attend a conference, and is an investigator on an investigator-initiated research grant funded by Pfizer Australia. WS Pomat has received funding from Pfizer Australia to attend a conference. A.H.J. van den Biggelaar has received support from Pfizer Australia and GSK Australia to attend conferences; she was awarded and received a Pfizer-supported Robert Austrian Award in Pneumococcal Vaccinology (2008); she is currently an employee of Crucell/Johnson and Johnson, The Netherlands. All work related to this publication was conducted prior to employment at Crucell/Johnson and Johnson. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. S Phuanukoonnon, J Francis, P Jacoby, PM Siba, JC Reeder, MP Alpers and Patrick G Holt have declared that no competing interests exist. Vaccines used in this trial were purchased from manufacturers.
Author Contributions
Conceived and designed the experiments: DL PCR JCR PGH AHvdB MPA. Performed the experiments: JF. Analyzed the data: PJ AHJvdB. Wrote the paper: DL WSP AHJvdB. Supervised enrollment, clinical follow-up and field work, and reported adverse events to the DSMB: SP. Oversaw conduct of immunological assays and reviewed all immunology data: WSP. Oversaw implementation of the clinical trial and provided administrative support: PMS JCR. Critically read and approved the final version of the manuscript: WSP AHJvdB SP JF PJ PMS MPA JCR PGH PCR DL.